OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of $1.01 billion. The enterprise value is $1.24 billion.
Important Dates
The next estimated earnings date is Monday, November 4, 2024, after market close.
| Earnings Date | Nov 4, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OPKO Health has 691.99 million shares outstanding. The number of shares has decreased by -3.27% in one year.
| Shares Outstanding | 691.99M |
| Shares Change (YoY) | -3.27% |
| Shares Change (QoQ) | -1.37% |
| Owned by Insiders (%) | 50.02% |
| Owned by Institutions (%) | 22.06% |
| Float | 281.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.48 |
| Forward PS | 1.27 |
| PB Ratio | 0.73 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.63 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.79 |
Financial Efficiency
Return on equity (ROE) is -16.59% and return on invested capital (ROIC) is -9.57%.
| Return on Equity (ROE) | -16.59% |
| Return on Assets (ROA) | -8.09% |
| Return on Capital (ROIC) | -9.57% |
| Revenue Per Employee | $182,283 |
| Profits Per Employee | -$61,857 |
| Employee Count | 3,930 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 9.26 |
Taxes
| Income Tax | -1.57M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.67% in the last 52 weeks. The beta is 1.63, so OPKO Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -2.67% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 1.28 |
| Relative Strength Index (RSI) | 42.39 |
| Average Volume (20 Days) | 3,503,187 |
Short Selling Information
The latest short interest is 98.37 million, so 14.21% of the outstanding shares have been sold short.
| Short Interest | 98.37M |
| Short Previous Month | 98.23M |
| Short % of Shares Out | 14.21% |
| Short % of Float | 34.97% |
| Short Ratio (days to cover) | 25.96 |
Income Statement
In the last 12 months, OPKO Health had revenue of $716.37 million and -$243.10 million in losses. Loss per share was -$0.33.
| Revenue | 716.37M |
| Gross Profit | 96.51M |
| Operating Income | -267.73M |
| Pretax Income | -244.67M |
| Net Income | -243.10M |
| EBITDA | -165.46M |
| EBIT | -267.73M |
| Loss Per Share | -$0.33 |
Full Income StatementBalance Sheet
The company has $40.58 million in cash and $269.45 million in debt, giving a net cash position of -$228.87 million or -$0.33 per share.
| Cash & Cash Equivalents | 40.58M |
| Total Debt | 269.45M |
| Net Cash | -228.87M |
| Net Cash Per Share | -$0.33 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 2.00 |
| Working Capital | 138.43M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$67.19 million and capital expenditures -$18.89 million, giving a free cash flow of -$86.07 million.
| Operating Cash Flow | -67.19M |
| Capital Expenditures | -18.89M |
| Free Cash Flow | -86.07M |
| FCF Per Share | -$0.12 |
Full Cash Flow StatementMargins
Gross margin is 13.47%, with operating and profit margins of -37.37% and -33.93%.
| Gross Margin | 13.47% |
| Operating Margin | -37.37% |
| Pretax Margin | -34.15% |
| Profit Margin | -33.93% |
| EBITDA Margin | -23.10% |
| EBIT Margin | -37.37% |
| FCF Margin | -11.74% |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.27% |
| Shareholder Yield | 3.27% |
| Earnings Yield | -24.06% |
| FCF Yield | -8.52% |
Dividend DetailsAnalyst Forecast
The average price target for OPKO Health is $2.75, which is 88.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.75 |
| Price Target Difference | 88.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.42 |
| Piotroski F-Score | 2 |